Dilip shanghvi

Sun Pharma has fared worse compared to its peers and the broad market. Graphic: Naveen Kumar Saini/Mint

Sun Pharma: One down, Halol to go

3 min read . 23 Mar 2018
Sun Pharma’s September quarter sales declined by 12% sequentially and by 44% from a year ago. Graphic: Subrata Jana/Mint

Sun Pharma: Still stuck on Halol

2 min read . 15 Nov 2017